Minimal change in HSV-2 seroreactivity: A cross-sectional Swedish population study

References

• Whitley RJ. Herpes simplex viruses. Fields Virology Volume 24th edn, DM Knipe, PM Howley. Lippincott, Williams & Wilkins. 2000; 2461–509
   Google Scholar
• Jonsson MK, Wahren B. Sexually transmitted herpes simplex viruses. Scand J Infect Dis 2004; 36: 93–101
   PubMed Web of Science ®Google Scholar
• Lowhagen GB, Tunback P, Andersson K, Bergstrom T, Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Inf 2000; 76: 179–82
   PubMedGoogle Scholar
• Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infections in Bergen, Norway. Acta Obstet Gynecol Scand 2000; 79: 693–6
   PubMedGoogle Scholar
• Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemtoher 2000; 45: 1–8
   PubMed Web of Science ®Google Scholar
• Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000; 181: 1454–7
   PubMed Web of Science ®Google Scholar
• Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30: 797–800
   PubMed Web of Science ®Google Scholar
• Benedetti JK, Zeh J, Selke S, Corey L. Frequency and reactivation of non-genital lesions among patients with genital herpes simplex virus. Am J Med 1995; 98: 237–42
   PubMed Web of Science ®Google Scholar
• Lowhagen GB, Tunback P, Bergstrom T. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol 2002; 82: 118–20
   PubMed Web of Science ®Google Scholar
• Tunback P, Bergstrom T, Andersson AS, Nordin P, Krantz I, Lowhagen GB. Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross-sectional study. Scand J Infect Dis 2003; 35: 498–502
   PubMed Web of Science ®Google Scholar
• Manavi K, McMillan A, Ogilvie M. Herpes simplex virus type 1 remains the principal cause of anogenital herpes in Edinburgh, Scotland. Sex Transm Dis 2004; 31: 322–4
   PubMedGoogle Scholar
• Coyle PV, O'Neill HJ, Wyatt DE, McCaughey C, Quah S, McBride MO. Emergence of herpes simplex type 1 as the main cause of recurrent genital ulcerative disease in women in Northern Ireland. J Clin Virol 2003; 27: 22–9
   PubMedGoogle Scholar
• Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341: 1432–8
   PubMed Web of Science ®Google Scholar
• Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, Brown DW. The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76: 183–7
   PubMed Web of Science ®Google Scholar
• Hashido M, Lee FK, Nahmias AJ, Tsugami H, Isomura S, Nagata Y, et al. An epidemiological study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect 1998; 120: 179–86
   PubMedGoogle Scholar
• Cherpes TL, Meyn LA, Hillier SL. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis 2005; 32: 84–9
   PubMed Web of Science ®Google Scholar
• Marrazzo JM, Stine K, Wald A. Prevalence and risk factors for infection with herpes simplex virus type-1 and -2 among lesbians. Sex Transm Dis 2003; 30: 890–5
   PubMed Web of Science ®Google Scholar
• Isacsohn M, Smetana Z, Rones ZZ, Raveh D, Diamant Y, Samueloff A, et al. A sero-epidemiological study of herpes virus type 1 and 2 infection in Israel. J Clin Virol 2002; 24: 85–92
   PubMedGoogle Scholar
• Bunzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PR. Seroepidemiology of herpes simplex virus type 1 and 2 in western and southern Switzerland in adults aged 25–74 y in 1992–93: a population-based study. BMC Infect Dis 2004; 4: 10
   PubMed Web of Science ®Google Scholar
• Fleming DT, McQuillan GM, Johnson RE, Nahmnias AJ, Aral SO, Lee FK, St Louis ME. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337: 1105–11
   PubMed Web of Science ®Google Scholar
• Eskild A, Jeansson S, Jenum PA. Antibodies against herpes simplex virus type 2 among pregnant women in Norway. Tidsskr Nor Laegeforen 1999; 119: 2323–6
   PubMedGoogle Scholar
• Hashido M, Kawana T, Matsunaga Y, Inouye S. Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan. Microbiol Immunol 1999; 43: 177–80
   PubMed Web of Science ®Google Scholar
• Gaytant MA, Steegers EAP, van Laere M, Semmekrot BA, Groen J, Weel JF, et al. Seroprevalences of herpes simplex virus type 1 and type 2 among pregnant women in the Netherlands. Sex Transm Dis 2002; 29: 710–4
   PubMed Web of Science ®Google Scholar
• Evans BA, Kell PD, Bond RA, MacRae KD, Slomka MJ, Brown DW. Predictors of seropositivity to herpes simplex virus type 2 in women. Int J STD AIDS 2003; 14: 30–6
   PubMedGoogle Scholar
• Suligoi, B, Calistri, A, Cusini, M, Palu, G, Italian Herpes Management Forum. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy. J Med Virol 2002;67:345–8.
   PubMedGoogle Scholar
• Gottlieb, SL, Douglas, JM, Schmid, DS, Bolan, G, Iatesta, M, Malotte, CK, , Project RESPECT Study Group, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in 5 sexually transmitted-disease clinics. J Infect Dis 2002;186:1381–9.
   PubMed Web of Science ®Google Scholar
• Hellenbrand W, Thierfelder W, Muller-Pebody, Hamouda O, Breuer T. Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997–1998. Eur J Clin Microbiol Infect Dis 2005; 24: 131–5
   PubMedGoogle Scholar
• Lowhagen GB, Berntsson M, Bonde E, Tunback P, Krantz I. Acceptance and outcome of herpes simplex virus type 2 antibody testing in patients attending an STD clinic – recognized and unrecognized infections. Acta Derm Venereol 2005; 85: 248–52
   PubMedGoogle Scholar
• Kamali A, Nunn AJ, Mulder DW, van Dyck E, Dobbins JG, Whitworth JAG. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Inf Dis 1999; 75: 98–102
   PubMed Web of Science ®Google Scholar
• Levi M, Rudén U, Wahren B. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies. Clin Diagn Lab Immunol 1996; 3: 265–9
   PubMedGoogle Scholar
• Ashley RL, Militoni J, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988; 26: 662–7
   PubMed Web of Science ®Google Scholar
• Parkes DL, Smith CM, Rose JM, Brandis J, Coates SR. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein. G J CLIN Microbiol 1991; 29: 778–81
   PubMed Web of Science ®Google Scholar
• Eriksson K, Bellner L, Gorander S, Lowhagen GB, Tunback P, Rydberg K, Liljeqvist JA. CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals. J Gen Virol 2004; 85: 2139–47
   PubMedGoogle Scholar
• Liljekvist JA, Trybala E, Svennerholm B, Jeansson S, Sjogren-Jansson E, Bergstrom T. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Vir 1998; 79: 1215–24
   PubMedGoogle Scholar
• Tunback P, Bergstrom T, Lowhagen GB., Hoebeke J, Liljeqvist JA. Type-specific reactivity of anti-glycoprotein G antibodies from herpes simplex virus-infected individuals is maintained by single or dual type-specific residues. J Gen Virol 2005; 86: 247–51
   PubMedGoogle Scholar
• Bottiger M, Gustavsson O, Svensson A. Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in 1991. Int J Epidemiol 1998; 27: 916–25
   PubMedGoogle Scholar
• Andrews N, Pebody RG, Berbers G, Blondeau C, Crovari P, Davidkin I, et al. The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 2000; 125: 127–43
   PubMed Web of Science ®Google Scholar
• Levi M, Rudén U, Carlberg H, Wahren B. The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies. J Clin Virol 1999; 12: 243–52
   PubMedGoogle Scholar
• Ashley, RL. Diagnostic procedures for viral rickettsial and chlamydial infections. 1995;22:375–8.
   Google Scholar
• Schmid, DS, Brown, DR, Nisenbaum, R, Burke, RL, Alexander, DA, Ashley, R, , et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999;37376–9.
   PubMedGoogle Scholar
• Janier M, Lassau F, Bloch J, Spindler E, Morel P, Gerard P, Aufrere A. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris. Int J STD AIDS 1999; 10: 522–6
   PubMedGoogle Scholar
• Bassett I, Donovan B, Bodsworth NJ, Field PR, Ho DW, Jeansson S, Cunningham AL. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre. Med J Austr 1994; 160: 697–700
   PubMed Web of Science ®Google Scholar
• Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol 2002; 190: 153–60
   PubMedGoogle Scholar
• Laubereau B, Zwahlen M, Neuenschwander B, Heininger U, Schaad UB, Desgrandchamps D. Herpes simplex virus type 1 and 2 in Switzerland. Schweiz Med Wochenschr 2000; 130: 143–50
   PubMedGoogle Scholar
• Howard M, Sellors JW, Jang D, Robinson NJ, Fearon M, Kaczorowski J, Chernesky M. Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada. J Clin Microbiol 2003; 41: 84–9
   PubMed Web of Science ®Google Scholar
• Auvert B, Ballard R, Campbell C, Carael M, Carton M, Fehler G, et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS 2001; 15: 885–98
   PubMed Web of Science ®Google Scholar
• Persson K, Mansson AS, Jonsson E, Nordenfelt E. Decline of herpes simplex virus type 2 and Chlamydia trachomatosis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995; 27: 195–9
   PubMed Web of Science ®Google Scholar
• Malkin JE, Morand P, Malvy D, Ly TD, Chanzy B, de Labareyre C, et al. Seroprevalence of HSV-1 and HSV-2 infection in the general French population. Sex Transm Infect 2002; 78: 201–3
   PubMed Web of Science ®Google Scholar
• Patrick, DM, Dawar, M, Cook, DA, Krajden, M, Ng HC, Rekart, ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women. Sex Transm Dis 2001;28:424–8.
   PubMedGoogle Scholar
• Bahrdt B, Rabenau H, Weber B, Eibner J, Doerr HW. Prevalence of herpes-simplex-virus type 2 specific antibodies in patients with different risks of infection. Z Hautkrank 1991; 67: 56–8
   Google Scholar
• Wutzler P, Doerr HW, Farber I, Eichorn U, Helbig B, Sauerbrei A, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations – relevance for the incidence of genital herpes. J Med Vir 2000; 61: 201–7
   PubMed Web of Science ®Google Scholar
• Arvaja M, Lehtinen M, Koskela P, Lappalainen M, Paavonen J, Vesikari T. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect 1999; 75: 168–71
   PubMed Web of Science ®Google Scholar
• Carvalho M, de Carvalho S, Pannuti CS, Sumita LM, de Souza VA. Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in 3 different populations in Campinas City, Brazil. Int J Infect Dis 1998/99; 3: 94–8
   PubMedGoogle Scholar
• Roest RW, van der Meijden WI, van Dijk G, Groen J, Mulder PG, Verjans GM, Osterhaus AD. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic. Int J Epidem 2001; 30: 580–8
   PubMedGoogle Scholar